12(11):2715-2719
IC50 Value: 27±5 nM(Ki) Target: 5-HT1A in vitro: Tandospirone is most potent at the 5-HT1A receptor
αvβ8 and α5β1
InChi: InChI=1S/C20H32O5
Flumatinib is currently in Phase I and II clinical trials in China for the treatment of chronic myelogenous leukemia (CML)
EHT 5372 Catalog No.:M16773-C 12(11):2715-2719EHT 5372 is a highly potent and selective inhibitor of DYRKs family kinases with IC50s of 0. 22, 0. 28, 10. 8, 93. 2, 22. 8, 88. 8, 59. 0, 7. 44, 221 nM for DYRK1A, DYRK1B , DYRK2 DYRK3 CLK1, CLK2, CLK4, GSK 3, GSK 3. Product information CAS Number: 1425945 63 6 Molecular Weight: 404. 27 Formula: C17H11Cl2N5OS Chemical Name: methyl 9 [(2,4 dichlorophenyl)amino] [1,3]thiazolo[5,4 f]quinazoline 2 carboximidate Smiles: